SUBSCRIBE
SUBSCRIBE

Dana-Farber Cancer Institute

NEWS
Genetown
“CYCLOPS” Genes May Serve as an Achilles’ Heel in Tumor Cells, Dana-Farber Cancer Institute and Broad Institute Study
August 16, 2012
 · 
1 min read
Genetown
Newly Identified ‘Beige Fat’ Cells Could Help Fight Obesity, Dana-Farber Cancer Institute Study
July 13, 2012
 · 
1 min read
Genetown
Antioxidant Beta-Carotene Use Safe During Radiation Treatment for Prostate Cancer, Dana-Farber Cancer Institute Study
June 1, 2012
 · 
1 min read
Genetown
Marked for Destruction: Newly Developed Compound Triggers Cancer Cell Death, Dana-Farber Cancer Institute Study
May 25, 2012
 · 
1 min read
Genetown
Mouse Study Sheds Light on How Diet May Affect Epilepsy, Dana-Farber Cancer Institute and Harvard Medical School Study
May 24, 2012
 · 
1 min read
Genetown
Hormone-Depleting Drug Shows Promise Against Localized High-Risk Prostate Tumors, Dana-Farber Cancer Institute Study
May 17, 2012
 · 
1 min read
Genetown
Target Set on Cancer Gene MCL1, Dana-Farber Cancer Institute Study
April 17, 2012
 · 
1 min read
Genetown
Dana-Farber Cancer Institute Researchers Identify Genetic Mutation Responsible for Most Cases of Waldenstrom’s Macroglobulinemia
December 16, 2011
 · 
1 min read
Genetown
Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Dana-Farber Cancer Institute Study
December 7, 2011
 · 
1 min read
Load More
JOBS
IN THE PRESS
Lone Star Bio
Susan G. Komen for the Cure Honored for $20 Million in Research Investments to Dana-Farber Cancer Institute
September 25, 2013
 · 
1 min read
Business
The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
June 7, 2013
 · 
4 min read
Business
BrainStorm Cell Therapeutics Inc. Partners With Dana-Farber Cancer Institute for NurOwn™ Production in Phase II ALS Clinical Trial
April 8, 2013
 · 
4 min read
Pharm Country
The Mikey Czech Foundation Contributes $500,000 to DIPG Research at Dana-Farber Cancer Institute - Harvard Medical School
April 2, 2013
 · 
5 min read
Business
Second Stem Cell Expert From Harvard University’s Dana-Farber Cancer Institute Joins Cryo-Cell International
November 13, 2012
 · 
3 min read
Business
GNS Healthcare, Dana-Farber Cancer Institute and Mount Sinai School of Medicine Collaborate to Build Computer Model of Multiple Myeloma
November 8, 2012
 · 
7 min read
Drug Development
Clinical Trials Going Active for Cellceutix Anti-Cancer Drug Kevetrin
October 8, 2012
 · 
3 min read
Drug Development
New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells
September 17, 2012
 · 
1 min read
Drug Development
Dana-Farber Cancer Institute’s Ursula A. Matulonis, MD Article on EntreMed, Inc.'s ENMD-2076 Published in the European Journal of Cancer
September 6, 2012
 · 
6 min read
Drug Development
Cellceutix Reports Its Very Novel Anti-Cancer Agent, Kevetrin, at Dana-Farber Cancer Institute for Start of Clinical Trials
August 6, 2012
 · 
4 min read
Load More